SuperworthTrulieve Cannabis EPS TRLV
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- −$2.41
- Latest quarter, Q2 FY26
- −$2.10
- Fiscal year 2025
- −$0.56
Trulieve Cannabis' earnings per share was −$2.41 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$2.10.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.56 | n/a |
| FY2024 | −$0.83 | n/a |
| FY2023 | −$2.28 | n/a |
| FY2022 | −$1.04 | −435% |
| FY2021 | $0.31 | −42% |
| FY2020 | $0.53 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$2.10 | n/a | −$2.41 | |
| Q1 FY26 | $0.02 | n/a | −$0.38 | |
| Q4 FY25 | −$0.22 | n/a | −$0.56 | |
| Q3 FY25 | −$0.11 | n/a | −$0.65 | |
| Q2 FY25 | −$0.07 | n/a | −$0.86 | |
| Q1 FY25 | −$0.16 | n/a | −$0.83 | |
| Q4 FY24 | −$0.31 | n/a | −$0.83 | |
| Q3 FY24 | −$0.32 | n/a | −$0.70 | |
| Q2 FY24 | −$0.04 | n/a | −$0.50 | |
| Q1 FY24 | −$0.16 | n/a | −$2.26 | |
| Q4 FY23 | −$0.18 | n/a | −$2.28 | |
| Q3 FY23 | −$0.12 | n/a | −$2.51 |
Against its peers
Companies in Chemicals nearest Trulieve Cannabis' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| TRLVTrulieve Cannabis | −$2.41 | |
| ROGRogers | $1.75 | |
| NGVTIngevity | $1.47 | |
| IOSPInnospec | $4.90 | +545% a year |
| FULFuller H B | $3.59 | +72% a year |
| WDFCWD 40 | $6.58 | +4% a year |
| CRONCronos | $0.20 | +300% a year |
| AVNTAvient | $1.85 | +43% a year |
| CBTCabot | $3.54 | −54% a year |
| FTKFlotek Industries | $0.99 | +125% a year |
| CSWCSW Industrials | $7.29 | −13% a year |
| Peer median | $2.69 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Trulieve Cannabis
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.